| 000 | 01544 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517223221.0 | ||
| 264 | 0 | _c20190926 | |
| 008 | 201909s 0 0 eng d | ||
| 022 | _a1098-6596 | ||
| 024 | 7 |
_a10.1128/AAC.00550-18 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPark, A Young J | |
| 245 | 0 | 0 |
_aPharmacokinetics of Tedizolid in Plasma and Sputum of Adults with Cystic Fibrosis. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _c09 2018 |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdministration, Intravenous _xmethods |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xblood |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 |
_aCystic Fibrosis _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethicillin-Resistant Staphylococcus aureus _xdrug effects |
| 650 | 0 | 4 |
_aOrganophosphates _xblood |
| 650 | 0 | 4 |
_aOxazoles _xblood |
| 650 | 0 | 4 |
_aPlasma _xmetabolism |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aSputum _xmetabolism |
| 700 | 1 | _aWang, Joshua | |
| 700 | 1 | _aJayne, Jordanna | |
| 700 | 1 | _aFukushima, Lynn | |
| 700 | 1 | _aRao, Adupa P | |
| 700 | 1 | _aD'Argenio, David Z | |
| 700 | 1 | _aBeringer, Paul M | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 62 _gno. 9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.00550-18 _zAvailable from publisher's website |
| 999 |
_c28542365 _d28542365 |
||